Global Gene Therapy Market Report 2021: Amid the COVID-19 Pandemic, the Market is Projected to Reach a Revised Size of $3.4 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global market for Gene Therapy estimated at US$970.5 Million in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 19.5% over the period 2020-2027.

Viral, one of the segments analyzed in the report, is projected to grow at a 19.7% CAGR to reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Viral segment is readjusted to a revised 17.6% CAGR for the next 7-year period. This segment currently accounts for a 11.1% share of the global Gene Therapy market.

The U.S. Accounts for Over 53.7% of Global Market Size in 2020, While China is Forecast to Grow at a 25.1% CAGR for the Period of 2020-2027

The Gene Therapy market in the U.S. is estimated at US$521.3 Million in the year 2020. The country currently accounts for a 53.71% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$107.9 Million in the year 2027 trailing a CAGR of 25.1% through 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.3% and 18.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 18.6% CAGR while Rest of European market (as defined in the study) will reach US$107.9 Million by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of COVID-19 and a Looming Global Recession
• A Prelude to Gene Therapy
• Classification of Gene Therapies
• COVID-19 Causes Gene Therapy Market to Buckle & Collapse
• COVID-19 Impact on Different Aspects of Gene Therapy
• Manufacturing & Delivery
• Research & Clinical Development
• Commercial Operations & Access
• Managing Derailed Operations
• Focus on Clinical Development Programs
• Targeting Manufacturing & Delivery Strategies
• Securing Supplies
• Remote Working
• Gene Therapy Set to Witness Rapid Growth Post COVID-19
• By Vector Type
• Viral Vectors Account For A Major Share Of The Market
• Adeno-Associated Virus Vectors
• Lentivirus
• Non-Viral Vectors To Witness Faster Growth
• US and Europe Dominate the Gene Therapy Market
• Oncology Represents the Largest Indication for Gene Therapy
• Market Outlook
• WORLD BRANDS

2. FOCUS ON SELECT PLAYERS

• Recent Market Activity
• Select Innovations
• Abeona Therapeutics Inc.
• Adaptimmune Therapeutics Plc
• Advantagene, Inc.
• Adverum Biotechnologies, Inc
• Akcea Therapeutics
• Alnylam Pharmaceuticals, Inc.
• Amgen Inc
• Anchiano Therapeutics, Inc.
• AnGes, Inc.
• Applied Genetic Technologies Corporation
• Audentes Therapeutics, Inc.
• Biogen
• bluebird bio, Inc.
• Chiesi Farmaceutici S.p.A
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Gilead Sciences, Inc.
• Intellia Therapeutics, Inc.
• Jazz Pharmaceuticals, plc.
• Juno Therapeutics, Inc
• Merck KGaA
• MolMed S.p.A.
• Novartis Gene Therapies
• Orchard Therapeutics plc
• REGENXBIO Inc.
• Sangamo Therapeutics, Inc.
• Sarepta Therapeutics, Inc.
• Sibiono GeneTech Co. Ltd.
• Spark Therapeutics, Inc.
• uniQure N.V.
• Voyager Therapeutics

3. MARKET TRENDS & DRIVERS

• Availability of Novel Therapies Drive Market Growth
• Select Approved Gene Therapy Products
• Adeno-associated Virus Vectors - A Leading Platform for Gene Therapy
• Lentiviral Vectors Witness Increasing Interest
• Rising Cancer Incidence Worldwide Spurs Demand for Gene Therapy
• Compelling Level of Technology & Innovation to Ignite Gene Therapy
• Promising Gene Therapy Innovations for Treatment of Inherited Retinal Diseases
• Gene Therapy Pivots M&A Activity in Dynamic Domain of Genomic Medicine
• M&As Rampant in Gene Therapy Space
• Gene Therapy Deals: 2018 and 2019
• Emphasis on Formulating Robust Regulatory Framework
• Strong Gene Therapy Pipeline
• Gene Therapy: Phase III Clinical Trials
• OHSU Implements First-Ever LCA10 Gene Therapy Clinical Trial with CRISPR
• Growing Funding for Gene Therapy Research
• Market Issues & Challenges

4. GLOBAL MARKET PERSPECTIVE

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 154

For more information about this report visit https://www.researchandmarkets.com/r/2skzha